Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Parkinson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Inflammation & Allergy Drug Targets|April 15, 2006
Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulationJohn F Parkinson
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 30, 2005
Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogsWilliam J Guilford, John F Parkinson
Current Vascular Pharmacology|January 29, 2008
Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation modelLe-Ning Zhang, John F Parkinson, Christopher Haskell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitorKoustubh Panda, Mamta Chawla-Sarkar, Cecile Santos, et al.
Molecular Pharmacology|February 28, 2003
Pharmacological interference with dimerization of human neuronal nitric-oxide synthase expressed in adenovirus-infected DLD-1 cellsHans-Jörg Habisch, Antonius C F Gorren, Haiying Liang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2007
Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonismBruce D Levy, Nicholas W Lukacs, Aaron A Berlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthaseMarc Whitlow, Marc Adler, David Davey, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2003
The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injuryPerenlei Enkhbaatar, Kazunori Murakami, Katsumi Shimoda, et al.
Burns : Journal of the International Society for Burn Injuries|February 22, 2011
Mechanistic aspects of inducible nitric oxide synthase-induced lung injury in burn traumaPerenlei Enkhbaatar, Jianpu Wang, Fiona Saunders, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Inflammation & Allergy Drug Targets|April 15, 2006
Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulationJohn F Parkinson
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 30, 2005
Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogsWilliam J Guilford, John F Parkinson
Current Vascular Pharmacology|January 29, 2008
Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation modelLe-Ning Zhang, John F Parkinson, Christopher Haskell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitorKoustubh Panda, Mamta Chawla-Sarkar, Cecile Santos, et al.
Molecular Pharmacology|February 28, 2003
Pharmacological interference with dimerization of human neuronal nitric-oxide synthase expressed in adenovirus-infected DLD-1 cellsHans-Jörg Habisch, Antonius C F Gorren, Haiying Liang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2007
Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonismBruce D Levy, Nicholas W Lukacs, Aaron A Berlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthaseMarc Whitlow, Marc Adler, David Davey, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2003
The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injuryPerenlei Enkhbaatar, Kazunori Murakami, Katsumi Shimoda, et al.
Burns : Journal of the International Society for Burn Injuries|February 22, 2011
Mechanistic aspects of inducible nitric oxide synthase-induced lung injury in burn traumaPerenlei Enkhbaatar, Jianpu Wang, Fiona Saunders, et al.
Pageof 2